Felix Dietlein

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Auger-Emitting Radionuclides in Radiopharmaceutical Research: Decay-Associated Processes, Vector-Dependent Localization, and Translational Perspectives.

Auger-Emitting Radionuclides in Radiopharmaceutical Research: Decay-Associated Processes, Vector-Dependent Localization, and Translational Perspectives.

Journal: International journal of molecular sciences

Published: June 25, 2026

Airborne Radioiodine: A Comparative View of Chemical Forms in Medicine, Nuclear Industry, and Fallout Scenarios.

Airborne Radioiodine: A Comparative View of Chemical Forms in Medicine, Nuclear Industry, and Fallout Scenarios.

Journal: International journal of molecular sciences

Published: November 25, 2025

Proteo-genomics-guided interpretation of somatic mutations in cancer genomes.

Proteo-genomics-guided interpretation of somatic mutations in cancer genomes.

Journal: Cancer cell

Published: September 28, 2025

Multi-modal characterization of transcriptional programs that drive metastatic cascades to solid sites and ascites in ovarian cancer.

Multi-modal characterization of transcriptional programs that drive metastatic cascades to solid sites and ascites in ovarian cancer.

Journal: bioRxiv : the preprint server for biology

Published: September 05, 2025

Overcoming Multidrug Resistance Using DNA-Localized Auger Emitters: A Comparative Analysis of Radiotoxicity in Breast Cancer Cells.

Overcoming Multidrug Resistance Using DNA-Localized Auger Emitters: A Comparative Analysis of Radiotoxicity in Breast Cancer Cells.

Journal: International journal of molecular sciences

Published: May 22, 2025

Radioiodine Exhalation Following Oral I-131 Administration in a Mouse Model.

Radioiodine Exhalation Following Oral I-131 Administration in a Mouse Model.

Journal: Biomedicines

Published: January 18, 2025

Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancer.

Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancer.

Journal: Nature communications

Published: January 15, 2025

Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy.

Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy.

Journal: EJNMMI research

Published: September 16, 2024

Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [131I]-Iodine-ERIC1 in Neuroblastoma-Bearing Mice.

Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [131I]-Iodine-ERIC1 in Neuroblastoma-Bearing Mice.

Journal: International journal of molecular sciences

Published: August 20, 2024

Localization and Tumor Growth Inhibition of I-131-Labeled Monoclonal Antibody ERIC1 in a Subcutaneous Xenograft Model of Small Cell Lung Cancer in SCID Mice.

Localization and Tumor Growth Inhibition of I-131-Labeled Monoclonal Antibody ERIC1 in a Subcutaneous Xenograft Model of Small Cell Lung Cancer in SCID Mice.

Journal: International journal of molecular sciences

Published: August 20, 2024

From Bench to Bedside: Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [89Zr]Zr-PSMA-DFO.

From Bench to Bedside: Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [89Zr]Zr-PSMA-DFO.

Journal: Molecules (Basel, Switzerland)

Published: November 21, 2023

Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.

Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.

Journal: JCI insight

Published: October 18, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026